Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cardiology].

L Kappenberger1, G Girod, L Schlueter

  • 1Service de cardiologie, CHUV, 1011 Lausanne. dir.car@chuv.hospvd.ch

Revue Medicale Suisse
|March 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Diagnosis and therapy of peripheral nerve injuries. The "integrated therapy concept"].

Der Unfallchirurg·1999
Same author

Bone marrow transplantation for autoimmune diseases.

BMJ (Clinical research ed.)·1999
Same author

Diagnostic value of ultrasonography in patients with palpable mammographically noncalcified breast tumors.

Acta radiologica (Stockholm, Sweden : 1987)·1999
Same author

Variability in the interpretation of ultrasonography in patients with palpable noncalcified breast tumors.

Acta radiologica (Stockholm, Sweden : 1987)·1999
Same author

[Hypoglycemic coma of long duration].

Revue medicale de la Suisse romande·1999
Same author

[Endocarditis manifesting as a spondylodiscitis and psoas abscess].

Revue medicale de la Suisse romande·1999
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Elderly heart failure patients benefit from beta blockers and anemia correction. Further research is needed on sleep apnea treatment, endocannabinoid system interventions, and identifying patients for implantable defibrillators.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pharmacology

Context:

  • Key therapeutic strategies for cardiovascular diseases in 2004 highlighted the importance of beta-blocker treatment for elderly heart failure patients.
  • Anemia correction was identified as crucial for improving symptoms and survival in heart failure patients.
  • The role of sleep apnea as a mortality factor in cardiovascular diseases warranted further investigation regarding treatment efficacy.

Purpose:

  • To review and consolidate significant therapeutic acquisitions in cardiovascular medicine for 2004.
  • To identify areas requiring further research, including the impact of sleep apnea treatment and endocannabinoid system interventions.
  • To emphasize the ongoing importance of coronary disease prevention and the judicious use of lipid-lowering drugs.

Summary:

Related Experiment Videos

  • Beta-blocker therapy is recommended for elderly patients with heart failure, alongside anemia correction to improve outcomes.
  • The therapeutic potential of interventions targeting the endocannabinoid system for weight and metabolic regulation is recognized.
  • Lipid-lowering drugs remain central to coronary disease prevention, with a trend towards lower lipid levels, necessitating caution with polypharmacy due to drug interaction risks.
  • The life-saving potential of implantable defibrillators in ventricular fibrillation is acknowledged, though patient selection remains a challenge.

Impact:

  • This review consolidates critical 2004 therapeutic insights for heart failure and cardiovascular disease management.
  • It highlights the need for continued research into novel therapeutic targets like the endocannabinoid system and the role of sleep apnea.
  • The findings underscore the importance of personalized medicine, particularly in the selection of patients for advanced interventions like implantable defibrillators.